Takeda Pharmaceutical (TAK) Receivables - Other: 2018-2025

Historic Receivables - Other for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $381.1 million.

  • Takeda Pharmaceutical's Receivables - Other rose 0.76% to $380.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $380.5 million, marking a year-over-year increase of 0.76%. This contributed to the annual value of $381.1 million for FY2025, which is 1.80% down from last year.
  • As of FY2025, Takeda Pharmaceutical's Receivables - Other stood at $381.1 million, which was down 1.80% from $388.1 million recorded in FY2024.
  • In the past 5 years, Takeda Pharmaceutical's Receivables - Other registered a high of $713.2 million during FY2021, and its lowest value of $381.1 million during FY2025.
  • In the last 3 years, Takeda Pharmaceutical's Receivables - Other had a median value of $388.1 million in 2024 and averaged $439.0 million.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Receivables - Other rose by 1.18% in 2022, and later decreased by 29.15% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Receivables - Other (MRY) stood at $713.2 million in 2021, then decreased by 1.18% to $704.8 million in 2022, then decreased by 22.28% to $547.8 million in 2023, then fell by 29.15% to $388.1 million in 2024, then decreased by 1.80% to $381.1 million in 2025.
  • Its Receivables - Other stands at $381.1 million for FY2025, versus $388.1 million for FY2024 and $547.8 million for FY2023.